Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

HR Pedia Kit - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/HR Pedia Kit

Approved

STANDARD

HR Pedia Kit

Amherst Laboratories, Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 77f5e6a661eccd63
Company: Amherst Laboratories, Inc.
Type: Standard

Approval Details

Approval Id: 77f5e6a661eccd63
Drug Approval Philippines Name: HR Pedia Kit
Product Name: HR Pedia Kit
Registration Number: DR-XY31206
Brand Name: HR Pedia Kit
Generic Name: Rifampicin; Isoniazid + Pyridoxine Hydrochloride
Dosage Form: Suspension(Rimaped) / Syrup(Comprilex)
Dosage Strength: 200 mg/5 mL;200 mg/12 mg per 5 mL
Manufacturer: Amherst Laboratories, Inc.
Trader: UNILAB, Inc.
Issuance Date: 28 April 2021
Expiry Date: 01 September 2026
Pharmacologic Category: Antituberculosis
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

77f5e6a661eccd63

Type

Standard

Back to Philippines FDA Approvals